Overby, S.J.; Cerro-Herreros, E.; Espinosa-Espinosa, J.; González-MartÃnez, I.; Moreno, N.; Fernández-Costa, J.M.; Balaguer-Trias, J.; Ramón-Azcón, J.; Pérez-Alonso, M.; Møller, T.;
et al. BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSALR Mice. Pharmaceutics 2023, 15, 1118.
https://doi.org/10.3390/pharmaceutics15041118
AMA Style
Overby SJ, Cerro-Herreros E, Espinosa-Espinosa J, González-MartÃnez I, Moreno N, Fernández-Costa JM, Balaguer-Trias J, Ramón-Azcón J, Pérez-Alonso M, Møller T,
et al. BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSALR Mice. Pharmaceutics. 2023; 15(4):1118.
https://doi.org/10.3390/pharmaceutics15041118
Chicago/Turabian Style
Overby, Sarah J., EstefanÃa Cerro-Herreros, Jorge Espinosa-Espinosa, Irene González-MartÃnez, Nerea Moreno, Juan M. Fernández-Costa, Jordina Balaguer-Trias, Javier Ramón-Azcón, Manuel Pérez-Alonso, Thorleif Møller,
and et al. 2023. "BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSALR Mice" Pharmaceutics 15, no. 4: 1118.
https://doi.org/10.3390/pharmaceutics15041118
APA Style
Overby, S. J., Cerro-Herreros, E., Espinosa-Espinosa, J., González-MartÃnez, I., Moreno, N., Fernández-Costa, J. M., Balaguer-Trias, J., Ramón-Azcón, J., Pérez-Alonso, M., Møller, T., LlamusÃ, B., & Artero, R.
(2023). BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSALR Mice. Pharmaceutics, 15(4), 1118.
https://doi.org/10.3390/pharmaceutics15041118
